$ANCN Announces Shareholder Approval of the Merger with Chemomab
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices 45.5M Private Financing
Anchiano shareholders approve all resolutions at shareholder meeting
The merged company is expected to receive approximate gross proceeds from the private financing of $45.5 million, which will be used to advance the Chemomab pipeline.
finance.yahoo.com/news/anchiano-announces-shareholder-approval-merger-215400351.html
Anchiano shareholders approve all resolutions at shareholder meeting
The merged company is expected to receive approximate gross proceeds from the private financing of $45.5 million, which will be used to advance the Chemomab pipeline.
finance.yahoo.com/news/anchiano-announces-shareholder-approval-merger-215400351.html
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.